Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion

Qaiser Bashir; Marc Braunstein; Tondre Buck; Cynthia Chmielewski; Brittany Hartmann; Murali Janakiram; Marisa A. McMahon; Laura Romundstad; Lynn Steele; Saad Z. Usmani; Kimberly Zwibel; Mohamed A. Kharfan-Dabaja

doi:10.1016/j.jtct.2023.08.028

Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion

Qaiser Bashir, Marc Braunstein, Tondre Buck, Cynthia Chmielewski, Brittany Hartmann, Murali Janakiram, Marisa A. McMahon, Laura Romundstad, Lynn Steele, Saad Z. Usmani, Kimberly Zwibel, Mohamed A. Kharfan-Dabaja

Stem Cell Transplantation

Research output: Contribution to journal › Review article › peer-review

Abstract

Autologous stem cell transplantation (ASCT) is a standard of care treatment for patients with multiple myeloma (MM). However, only 20% to 30% of patients with MM for whom the procedure is indicated undergo ASCT. Barriers to ASCT may be informational, financial, logistic, or cultural and may affect patients and treating oncologists. Available and accessible accurate ASCT-related information is essential to overcome these barriers. Such resources can be created by blood and marrow transplantation societies and patient advocacy groups, ideally in collaboration with MM specialists at transplant centers. An umbrella office at the society level is also recommended to connect oncologists, advocacy groups, and transplantation specialists; provide informational resources to patients; and conduct research into region- and population-specific barriers to ASCT.

Original language	English (US)
Pages (from-to)	666-673
Number of pages	8
Journal	Transplantation and Cellular Therapy
Volume	29
Issue number	11
DOIs	https://doi.org/10.1016/j.jtct.2023.08.028
State	Published - Nov 2023

Keywords

Autologous transplantation
Barriers to treatment
Clinical decision making
Multiple myeloma

ASJC Scopus subject areas

Immunology and Allergy
Molecular Medicine
Hematology
Cell Biology
Transplantation

Access to Document

10.1016/j.jtct.2023.08.028

Cite this

Bashir, Q., Braunstein, M., Buck, T., Chmielewski, C., Hartmann, B., Janakiram, M., McMahon, M. A., Romundstad, L., Steele, L., Usmani, S. Z., Zwibel, K., & Kharfan-Dabaja, M. A. (2023). Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion. Transplantation and Cellular Therapy, 29(11), 666-673. https://doi.org/10.1016/j.jtct.2023.08.028

Bashir, Q, Braunstein, M, Buck, T, Chmielewski, C, Hartmann, B, Janakiram, M, McMahon, MA, Romundstad, L, Steele, L, Usmani, SZ, Zwibel, K & Kharfan-Dabaja, MA 2023, 'Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion', Transplantation and Cellular Therapy, vol. 29, no. 11, pp. 666-673. https://doi.org/10.1016/j.jtct.2023.08.028

@article{b73ddffec8f446ad85c1784f930a61d4,

title = "Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion",

abstract = "Autologous stem cell transplantation (ASCT) is a standard of care treatment for patients with multiple myeloma (MM). However, only 20% to 30% of patients with MM for whom the procedure is indicated undergo ASCT. Barriers to ASCT may be informational, financial, logistic, or cultural and may affect patients and treating oncologists. Available and accessible accurate ASCT-related information is essential to overcome these barriers. Such resources can be created by blood and marrow transplantation societies and patient advocacy groups, ideally in collaboration with MM specialists at transplant centers. An umbrella office at the society level is also recommended to connect oncologists, advocacy groups, and transplantation specialists; provide informational resources to patients; and conduct research into region- and population-specific barriers to ASCT.",

keywords = "Autologous transplantation, Barriers to treatment, Clinical decision making, Multiple myeloma",

author = "Qaiser Bashir and Marc Braunstein and Tondre Buck and Cynthia Chmielewski and Brittany Hartmann and Murali Janakiram and McMahon, {Marisa A.} and Laura Romundstad and Lynn Steele and Usmani, {Saad Z.} and Kimberly Zwibel and Kharfan-Dabaja, {Mohamed A.}",

note = "Publisher Copyright: {\textcopyright} 2023",

year = "2023",

month = nov,

doi = "10.1016/j.jtct.2023.08.028",

language = "English (US)",

volume = "29",

pages = "666--673",

journal = "Transplantation and Cellular Therapy",

issn = "2666-6367",

publisher = "Elsevier BV",

number = "11",

}

TY - JOUR

T1 - Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma

T2 - Recommendations from a Multidisciplinary Roundtable Discussion

AU - Bashir, Qaiser

AU - Braunstein, Marc

AU - Buck, Tondre

AU - Chmielewski, Cynthia

AU - Hartmann, Brittany

AU - Janakiram, Murali

AU - McMahon, Marisa A.

AU - Romundstad, Laura

AU - Steele, Lynn

AU - Usmani, Saad Z.

AU - Zwibel, Kimberly

AU - Kharfan-Dabaja, Mohamed A.

PY - 2023/11

Y1 - 2023/11

N2 - Autologous stem cell transplantation (ASCT) is a standard of care treatment for patients with multiple myeloma (MM). However, only 20% to 30% of patients with MM for whom the procedure is indicated undergo ASCT. Barriers to ASCT may be informational, financial, logistic, or cultural and may affect patients and treating oncologists. Available and accessible accurate ASCT-related information is essential to overcome these barriers. Such resources can be created by blood and marrow transplantation societies and patient advocacy groups, ideally in collaboration with MM specialists at transplant centers. An umbrella office at the society level is also recommended to connect oncologists, advocacy groups, and transplantation specialists; provide informational resources to patients; and conduct research into region- and population-specific barriers to ASCT.

AB - Autologous stem cell transplantation (ASCT) is a standard of care treatment for patients with multiple myeloma (MM). However, only 20% to 30% of patients with MM for whom the procedure is indicated undergo ASCT. Barriers to ASCT may be informational, financial, logistic, or cultural and may affect patients and treating oncologists. Available and accessible accurate ASCT-related information is essential to overcome these barriers. Such resources can be created by blood and marrow transplantation societies and patient advocacy groups, ideally in collaboration with MM specialists at transplant centers. An umbrella office at the society level is also recommended to connect oncologists, advocacy groups, and transplantation specialists; provide informational resources to patients; and conduct research into region- and population-specific barriers to ASCT.

KW - Autologous transplantation

KW - Barriers to treatment

KW - Clinical decision making

KW - Multiple myeloma

UR - http://www.scopus.com/inward/record.url?scp=85173266866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85173266866&partnerID=8YFLogxK

U2 - 10.1016/j.jtct.2023.08.028

DO - 10.1016/j.jtct.2023.08.028

M3 - Review article

C2 - 37661071

AN - SCOPUS:85173266866

SN - 2666-6367

VL - 29

SP - 666

EP - 673

JO - Transplantation and Cellular Therapy

JF - Transplantation and Cellular Therapy

IS - 11

ER -

Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this